Search Legislation

Advanced Search

The Misuse of Drugs Regulations 2001

Help about what version

What Version

Help about advanced features

Advanced Features

Changes to legislation:

There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Misuse of Drugs Regulations 2001. Any changes that have already been made by the team appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.

View outstanding changes

Changes and effects yet to be applied to Schedule 4:

  • Sch. 4 Pt. 1 para. 1 word inserted by S.I. 2024/248 reg. 2(4)
  • Regulations applied (with modifications) by S.I. 2015/1027 art. 3(2) (This amendment not applied to legislation.gov.uk. This Order was not approved by resolution of each House of Parliament within 40 days beginning with the day on which the Order was made)

Changes and effects yet to be applied to the whole Instrument associated Parts and Chapters:

Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):

  • reg. 19(1)(c) inserted by S.I. 2006/1450 reg. 7(1) (This amendment not applied to legislation.gov.uk. The commencement date of regs. 7(1), 10 was changed to 1.1.2008 by S.I. 2006/2178, regs. 1(1), 7 and then regs. 7(1), 10 were omitted on 16.8.2007 before they came into force by virtue of S.I. 2007/2154, regs. 2(1), 5(3))

Commencement Orders yet to be applied to the The Misuse of Drugs Regulations 2001

Commencement Orders bringing legislation that affects this Instrument into force:

Regulation 3

SCHEDULE 4U.K.

PART IU.K. CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 22, 23, 26 AND 27

1.  The following substances and products, namely—U.K.

  • Alprazolam

  • Aminorex

  • Bromazepam

  • Brotizolam

  • Camazepam

  • Chlordiazepoxide

  • [F11–(3–chlorophenyl)piperazine]

  • [F11–(3–chlorophenyl)–4–(3–chloropropyl)piperazine]

  • Clobazam

  • Clonazepam

  • Clorazepic acid

  • Clotiazepam

  • Cloxazolam

  • Delorazepam

  • Diazepam

  • Estazolam

  • Ethyl loflazepate

  • Fencamfamin

  • Fenproporex

  • Fludiazepam

  • Flurazepam

  • Halazepam

  • Haloxazolam

  • F2...

  • F3...

  • Ketazolam

  • Loprazolam

  • Lorazepam

  • Lormetazepam

  • Medazepam

  • Mefenorex

  • Mesocarb

  • F4...

  • Nimetazepam

  • Nitrazepam

  • Nordazepam

  • Oxazepam

  • Oxazolam

  • Pemoline

  • Pinazepam

  • Prazepam

  • Pyrovalerone

  • Tetrazepam

  • Triazolam

  • N-Ethylamphetamine

  • [F5Zaleplon]

  • [F6Zolpidem]

  • [F7Zopiclone]

Textual Amendments

F6Word in Sch. 4 Pt. 1 para. 1 inserted (1.7.2003) by The Misuse of Drugs (Amendment) Regulations 2003 (S.I. 2003/1432), regs. 1, 2(3)(b)

2.  Any stereoisomeric form of a substance specified in paragraph 1.U.K.

3.  Any salt of a substance specified in paragraph 1 or 2.U.K.

4.  Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 3, not being a preparation specified in Schedule 5.U.K.

[F85.  A liquid formulation—U.K.

(a)containing a botanical extract of cannabis—

(i)with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and

(ii)where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,

(b)which is dispensed through a metered dose pump as a mucosal mouth spray, and

(c)which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on 16th June 2010]

Textual Amendments

PART IIU.K. [F9Controlled Drugs Excepted From the Prohibition on Possession; Excluded from the Application of Offences Arising from the Prohibition on Importation and Exportation when Carried Out in Person for Administration to That Person; and Subject to the Requirements of Regulations 22, 23, 26 and 27]

Textual Amendments

1.  The following substances, namely—U.K.

  • [F105α–Androstane–3,17–diol]

  • [F10Androst-4-ene-3,17-diol]

  • [F101–Androstenediol]

  • [F101–Androstenedione]

  • [F114-Androstene-3, 17-dione]

  • [F125–Androstenedione]

  • [F115-Androstene-3, 17 diol]

  • Atamestane

  • Bolandiol

  • Bolasterone

  • Bolazine

  • Boldenone

  • [F13Boldione]

  • Bolenol

  • Bolmantalate

  • Calusterone

  • 4-Chloromethandienone

  • Clostebol

  • [F14Danazol]

  • [F14Desoxymethyltestosterone]

  • [F15Dienedione (estra-4, 9-diene-3,17-dione)]

  • Drostanolone

  • Enestebol

  • Epitiostanol

  • Ethyloestrenol

  • Fluoxymesterone

  • Formebolone

  • Furazabol

  • [F16Gestrinone]

  • [F163–Hydroxy–5α–androstan–17–one]

  • Mebolazine

  • Mepitiostane

  • Mesabolone

  • Mestanolone

  • Mesterolone

  • Methandienone

  • Methandriol

  • Methenolone

  • Methyltestosterone

  • Metribolone

  • Mibolerone

  • Nandrolone

  • [F1719–Norandrostenedione]

  • [F1819-Nor-4-Androstene-3, 17-dione]

  • [F1819-Nor-5-Androstene-3, 17 diol]

  • [F1919–Norandrosterone]

  • Norboletone

  • Norclostebol

  • Norethandrolone

  • [F2019–Noretiocholanolone]

  • Ovandrotone

  • Oxabolone

  • Oxandrolone

  • Oxymesterone

  • Oxymetholone

  • Prasterone

  • Propetandrol

  • [F21Prostanozol]

  • Quinbolone

  • Roxibolone

  • Silandrone

  • Stanolone

  • Stanozolol

  • Stenbolone

  • Testosterone

  • [F22Tetrahydrogestrinone]

  • Thiomesterone

  • Trenbolone

Textual Amendments

F11Words in Sch. 4 Pt. 2 para. 1 inserted (1.7.2003) by The Misuse of Drugs (Amendment) Regulations 2003 (S.I. 2003/1432), regs. 1, 2(4)(a)

F18Words in Sch. 4 Pt. 2 para. 1 inserted (1.7.2003) by The Misuse of Drugs (Amendment) Regulations 2003 (S.I. 2003/1432), regs. 1, 2(4)(b)

2.  Any compound (not being Trilostane or a compound for the time being specified in paragraph 1 of this Part of this Schedule) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say -U.K.

(a)by further substitution at position 17 by a methyl or ethyl group;

(b)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(c)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(d)by fusion of ring A with a heterocyclic system.

3.  Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in paragraph 1 or described in paragraph 2 of this Part of this Schedule.U.K.

4.  The following substances, namely—U.K.

  • Chorionic Gonadotrophin (HCG)

  • Clenbuterol

  • Non-human chorionic gonadotrophin

  • Somatotropin

  • Somatrem

  • Somatropin

  • [F23Zeranol]

  • [F23Zilpaterol]

Textual Amendments

5.  Any stereoisomeric form of a substance specified or described in any of paragraphs 1 to 4 of this Part of this Schedule.U.K.

6.  Any salt of a substance specified or described in any of paragraphs 1 to 5 of this Part of this Schedule.U.K.

7.  Any preparation or other product containing a substance or product specified or described in any of paragraphs 1 to 6 of this Part of this Schedule, not being a preparation specified in Schedule 5.U.K.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources